# METHOTREXATE SODIUM
> **ANDA220225** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-04-15
## Drug
- **FDA Application Number:** ANDA220225
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHOTREXATE SODIUM
- **Generic name:** METHOTREXATE
- **Active ingredients:** METHOTREXATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2026-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220225)
---
*AI Analytics · CC0 1.0*